Corporate Info Message from Managememnt
Chairman |
President & CEO |
Dear Friends of aRigen,
At aRigen, a drug discovery and development company based in Japan, we are committed to discovering breakthrough pharmaceutical seeds in Japan in co-operation with leading Japanese life scientists, and developing innovative pharmaceutical products for the entire global population.
Our primary R&D focus is infectious disease, a therapeutic category that generates more than 10% of worldwide pharmaceutical sales but is largely overlooked by major drug companies. In addition, multi-drug resistant infections are seriously threatening global health. As aRigen is uniquely positioned as a leading R&D company in anti-infectives, we are determined to help patients cure infections and enjoy better lives. This mission is the cornerstone of our corporate social responsibility, and we believe contributions to the health of society will create lasting and sustainable shareholder value.
Welcome to our homepage! It will provide you with an overview on our R&D projects, product pipeline and corporate information. Should you need further information, please feel free to contact us.
Sincerely yours,